Amarin Corp Plc (AMRN)

[ilovetech]

HDK, Trig> 135 SOC guidelines includes >500 Marine Pop. Regardless of what's on the Generics label, Generics have to know, as do Doctors, both risk factors should be treated, and to ignore CVD in favor of the other is malpractice. That's the whole enchalada right there. It's in plane sight. I don't know about the Opotex case, but there's no grey area here. If the court agrees that a strict Marine Label can avoid infringement, then the court is COMPLICIT to incentivising Generics to cause HARM to society, when in fact it's known that Marine patients are at high RISK for CVD, and should be treated for both risk factors, not one in isolation.

ILT